Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product

Nature
|December 19, 1985
PubMed

Insights

Steroid receptors, like the human glucocorticoid receptor (hGR), share structural similarities with viral oncogenes, suggesting a link between steroid hormone signaling and cancer development. This discovery offers insights into oncogenesis and potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Oncology

Background:

  • Steroid-receptor interactions regulate gene expression, influencing cell growth, development, and differentiation.
  • Steroid hormones are implicated in abnormal growth regulation in tumors.
  • The human glucocorticoid receptor (hGR) exists in two protein forms (alpha and beta).

Purpose of the Study:

  • To investigate the structural relationship between human glucocorticoid receptors and viral oncogenes.
  • To explore the potential role of steroid receptor-like molecules in oncogenesis.

Main Methods:

  • Comparative analysis of protein domain structures.
  • Identification of homologous regions between hGR and viral/Drosophila proteins.

Main Results:

  • Both hGR alpha and beta forms share domain structures with the v-erb-A oncogene product.
  • Steroid receptor genes and the c-erb-A proto-oncogene likely evolved from a common ancestral gene.
  • A homologous region was identified between hGR and Drosophila homoeotic proteins.

Conclusions:

  • The v-erb-A oncogene may contribute to oncogenicity through aberrant steroid receptor-like activity.
  • Transacting factors may play a role in cellular transformation via this mechanism.
  • Structural homology suggests a conserved regulatory pathway across species and viral oncogenes.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: